A phase II study of [fam-] trastuzumab deruxtecan (DS-8201a) in HER2-overexpressing or -mutated advanced non-small cell lung cancer
DOI
オープンアクセス
この論文をさがす
収録刊行物
-
- Annals of Oncology
-
Annals of Oncology 30 ii66-ii67, 2019-04-01
Elsevier BV